AbbVie is near a deal to buy Allergan for more than $60 billion, as the two drugmakers bet a combination will deliver new sources of growth
Botox maker Allergan has a market capitalization of $42.47 billion, based on Monday’s close, according to FactSet. Photo: Richard Drew/Associated Press By Cara Lombardo, Jonathan D. Rockoff and Dana Cimilluca Updated June 25, 2019 6:32 am ET AbbVie Inc. ABBV -0.42% is nearing a deal to buy Allergan AGN -0.
Buying Dublin-based Allergan would deliver a dominant position in the $8 billion-plus market for Botox and other beauty drugs, as well as a number of popular eye treatments, as AbbVie braces for the end of patent protection for the world’s top-selling drug, Humira. Allergan’s nearly $16 billion in yearly revenue would also give AbbVie another source of cash to hunt for a new generation of products.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The $60 Amazon Hair Dryer that Changed My Life“The more I use this thing, the more I like it. Those 3,286 reviews were right: You need this dryer in your life”
Read more »
Eldorado Resorts takes on bigger rivals with $8.5 billion Caesars buyU.S. casino operator Eldorado Resorts Inc has agreed to buy rival Caesars Entert...
Read more »
Eldorado Resorts to buy Caesars Entertainment for about $8.5 billionEldorado Resorts Inc has agreed to buy Caesars Entertainment Corp for about $8.5...
Read more »
Tired of Fighting for Business, Missouri and Kansas Near Cease-Fire Deal Over IncentivesKansas and Missouri are gearing up for a truce to an economic border war that has cost hundreds of millions of dollars and created barely any new jobs.
Read more »
Caesars' stock soars after Eldorado buyout deal values casino operator at about $8.6 billionShares of Caesars Entertainment Corp. soared 16% toward an 11-month high in premarket trading Monday, after the casino operator agreed to be bought out by...
Read more »
Circor rejects Crane's buyout deal valued at $1.7 billionCircor International Inc. said Monday it has rejected the unsolicited buyout bid from Crane Co. given that it 'substantially undervalues' the flow...
Read more »